This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Brian Vastag

JAMA. 2002;287:827-828.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington—After a decade of scrutinizing family trees and chromosomes, a multi-institutional team has discovered two genetic mutations linked to prostate cancer. Preliminary evidence marks the defects in the RNASEL gene on chromosome 1 as responsible for just a tiny percentage of all cases. However, a bit of tantalizing data suggests that the cancer in these cases may be among the most aggressive.

"The individuals who carry the mutations seem to present with cancer that leads to poor outcomes," said John Carpten, PhD, of the National Human Genome Research Institute (NHGRI), Bethesda, Md. As lead author on a research letter, Carpten reports discovery of two mutations in RNASEL, each from a different family with an overwhelming history of prostate cancer (Nat Genet. 2002;30:181-184 and published online January 22, 2002).

TWO AFFECTED FAMILIES

In the first family, four brothers had identical mutations in RNASEL. Three presented . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chromosomal Instability in Peripheral Blood Lymphocytes and Risk of Prostate Cancer
El-Zein et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:748-752.
ABSTRACT | FULL TEXT  

{beta}-Catenin-related Anomalies in Apoptosis-resistant and Hormone-refractory Prostate Cancer Cells
de la Taille et al.
Clin. Cancer Res. 2003;9:1801-1807.
ABSTRACT | FULL TEXT